Dinutuximab
Product Specifications
UNSPSC Description
Dinutuximab (Unituxin; APN-311) is a chimeric, human-murine, anti-GD2 monoclonal antibody. Dinutuximab potently enlongs event-free survival and overall survival, in high-risk neuroblastoma treatment, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), aldesleukin (interleukin-2 [IL-2]), and isotretinoin (13-cis-retinoic acid [RA])[1].
Target Antigen
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dinutuximab.html
Purity
99.0
Solubility
10 mM in DMSO|H2O
Smiles
[Dinutuximab]
References & Citations
[1]Ploessl C, et al. Dinutuximab: An Anti-GD2 Monoclonal Antibody for High-Risk Neuroblastoma. Ann Pharmacother. 2016 May;50(5):416-22.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P9933/Dinutuximab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P9933/Dinutuximab-SDS-MedChemExpress.pdf
Clinical Information
Launched
CAS Number
1363687-32-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![5',5''''- (Buta-1,3-diyne-1,4-diyl) bis (([1,1':3',1''-terphenyl]-4,4''-dicarboxylic acid) )](https://cdn.genprice.uk/genprice/genprice5.png)
OR1041029-01 100 mg
5',5''''- (Buta-1,3-diyne-1,4-diyl) bis (([1,1':3',1''-terphenyl]-4,4''-dicarboxylic acid) )
Ask
View Details OR1041029-02 250 mg
5',5''''- (Buta-1,3-diyne-1,4-diyl) bis (([1,1':3',1''-terphenyl]-4,4''-dicarboxylic acid) )
Ask
View Details OR1041029-03 1 g
5',5''''- (Buta-1,3-diyne-1,4-diyl) bis (([1,1':3',1''-terphenyl]-4,4''-dicarboxylic acid) )
Ask
View Details 